High Burden of 30‐Day Readmissions After Acute Venous Thromboembolism in the United States

Background Venous thromboembolism (VTE) is the third leading cause of vascular disease and accounts for $10 billion in annual US healthcare costs. The nationwide burden of 30‐day readmissions after such events has not been comprehensively assessed. Methods and Results We analyzed adults ≥18 years of...

Full description

Bibliographic Details
Main Authors: Eric A. Secemsky, Kenneth Rosenfield, Kevin F. Kennedy, Michael Jaff, Robert W. Yeh
Format: Article
Language:English
Published: Wiley 2018-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.009047
_version_ 1828878366828134400
author Eric A. Secemsky
Kenneth Rosenfield
Kevin F. Kennedy
Michael Jaff
Robert W. Yeh
author_facet Eric A. Secemsky
Kenneth Rosenfield
Kevin F. Kennedy
Michael Jaff
Robert W. Yeh
author_sort Eric A. Secemsky
collection DOAJ
description Background Venous thromboembolism (VTE) is the third leading cause of vascular disease and accounts for $10 billion in annual US healthcare costs. The nationwide burden of 30‐day readmissions after such events has not been comprehensively assessed. Methods and Results We analyzed adults ≥18 years of age with hospitalizations associated with acute VTE between January 1, 2010, and December 31, 2014, in the Nationwide Readmissions Database. International Classification of Disease, Ninth Revision, Clinical Modification (ICD‐9‐CM) codes were used to identify hospitalizations associated with acute pulmonary embolism or deep vein thrombosis. The primary outcome was the rate of unplanned 30‐day readmission. Hierarchical logistic regression was used to calculate hospital‐specific 30‐day risk‐standardized readmission rates, a marker of healthcare quality. Among 1 176 335 hospitalizations with acute VTE, in‐hospital death occurred in 6.2%. VTE was associated with malignancy in 19.7%, recent surgery in 19.3%, recent trauma in 4.6%, hypercoagulability in 3.3%, and pregnancy in 1.0%. Among survivors to discharge, the 30‐day readmission rate was 17.5%, with no significant difference in rates across study years (17.4%–17.7%; P=0.10 for trend). Major predictors of readmission were malignancy (relative risk, 1.49, 95% confidence interval 1.47‐1.50), Medicaid insurance (relative risk, 1.48, 95% confidence interval 1.46‐1.50), and nonelective index admission (relative risk, 1.31, 95% confidence interval 1.29‐1.33). Top causes of readmission included sepsis (9.6%) and procedural complications (8.1%). Median rehospitalization costs were $9781.7 (interquartile range, $5430.7–$18 784.1), and 8.1% died during readmission. The interquartile range in risk‐standardized readmission rates was 16.6% to 18.3%, suggesting modest interhospital heterogeneity in readmission risk. Conclusions Nearly 1 in 5 patients with acute VTE were readmitted within 30 days. Predictors and causes of readmission were primarily related to patient characteristics and complications from comorbid conditions, whereas healthcare quality had a moderate impact on readmission risk.
first_indexed 2024-12-13T09:05:00Z
format Article
id doaj.art-e793b2f301ac407fb9fae5ae7bdacf4f
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-12-13T09:05:00Z
publishDate 2018-07-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-e793b2f301ac407fb9fae5ae7bdacf4f2022-12-21T23:53:06ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802018-07-0171310.1161/JAHA.118.009047High Burden of 30‐Day Readmissions After Acute Venous Thromboembolism in the United StatesEric A. Secemsky0Kenneth Rosenfield1Kevin F. Kennedy2Michael Jaff3Robert W. Yeh4Division of Cardiology Department of Medicine Massachusetts General Hospital Boston MADivision of Cardiology Department of Medicine Massachusetts General Hospital Boston MASaint Luke's Mid‐America Heart Institute Kansas City MODivision of Cardiology Department of Medicine Massachusetts General Hospital Boston MAHarvard Medical School Boston MABackground Venous thromboembolism (VTE) is the third leading cause of vascular disease and accounts for $10 billion in annual US healthcare costs. The nationwide burden of 30‐day readmissions after such events has not been comprehensively assessed. Methods and Results We analyzed adults ≥18 years of age with hospitalizations associated with acute VTE between January 1, 2010, and December 31, 2014, in the Nationwide Readmissions Database. International Classification of Disease, Ninth Revision, Clinical Modification (ICD‐9‐CM) codes were used to identify hospitalizations associated with acute pulmonary embolism or deep vein thrombosis. The primary outcome was the rate of unplanned 30‐day readmission. Hierarchical logistic regression was used to calculate hospital‐specific 30‐day risk‐standardized readmission rates, a marker of healthcare quality. Among 1 176 335 hospitalizations with acute VTE, in‐hospital death occurred in 6.2%. VTE was associated with malignancy in 19.7%, recent surgery in 19.3%, recent trauma in 4.6%, hypercoagulability in 3.3%, and pregnancy in 1.0%. Among survivors to discharge, the 30‐day readmission rate was 17.5%, with no significant difference in rates across study years (17.4%–17.7%; P=0.10 for trend). Major predictors of readmission were malignancy (relative risk, 1.49, 95% confidence interval 1.47‐1.50), Medicaid insurance (relative risk, 1.48, 95% confidence interval 1.46‐1.50), and nonelective index admission (relative risk, 1.31, 95% confidence interval 1.29‐1.33). Top causes of readmission included sepsis (9.6%) and procedural complications (8.1%). Median rehospitalization costs were $9781.7 (interquartile range, $5430.7–$18 784.1), and 8.1% died during readmission. The interquartile range in risk‐standardized readmission rates was 16.6% to 18.3%, suggesting modest interhospital heterogeneity in readmission risk. Conclusions Nearly 1 in 5 patients with acute VTE were readmitted within 30 days. Predictors and causes of readmission were primarily related to patient characteristics and complications from comorbid conditions, whereas healthcare quality had a moderate impact on readmission risk.https://www.ahajournals.org/doi/10.1161/JAHA.118.009047deep vein thrombosispulmonary embolismreadmissionvenous thromboembolism
spellingShingle Eric A. Secemsky
Kenneth Rosenfield
Kevin F. Kennedy
Michael Jaff
Robert W. Yeh
High Burden of 30‐Day Readmissions After Acute Venous Thromboembolism in the United States
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
deep vein thrombosis
pulmonary embolism
readmission
venous thromboembolism
title High Burden of 30‐Day Readmissions After Acute Venous Thromboembolism in the United States
title_full High Burden of 30‐Day Readmissions After Acute Venous Thromboembolism in the United States
title_fullStr High Burden of 30‐Day Readmissions After Acute Venous Thromboembolism in the United States
title_full_unstemmed High Burden of 30‐Day Readmissions After Acute Venous Thromboembolism in the United States
title_short High Burden of 30‐Day Readmissions After Acute Venous Thromboembolism in the United States
title_sort high burden of 30 day readmissions after acute venous thromboembolism in the united states
topic deep vein thrombosis
pulmonary embolism
readmission
venous thromboembolism
url https://www.ahajournals.org/doi/10.1161/JAHA.118.009047
work_keys_str_mv AT ericasecemsky highburdenof30dayreadmissionsafteracutevenousthromboembolismintheunitedstates
AT kennethrosenfield highburdenof30dayreadmissionsafteracutevenousthromboembolismintheunitedstates
AT kevinfkennedy highburdenof30dayreadmissionsafteracutevenousthromboembolismintheunitedstates
AT michaeljaff highburdenof30dayreadmissionsafteracutevenousthromboembolismintheunitedstates
AT robertwyeh highburdenof30dayreadmissionsafteracutevenousthromboembolismintheunitedstates